Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
16 April 2019
Closing Date:
13 May 2019
Location(s):
FRI12 Gironde (FR FRANCE)
Description:

Provision of drugs: hormones, muscle and skeleton, antidotes (intermediate procedure) - HMA19.


Argipressin Inj

Sl no1: 40ui / 2ml soil to be diluted for perf-qty is. 1st period: 1,325


Triptoreline Lp 1125mg (Ind Psychiatry)

Sl no1: 11,25mg powder and solvent for susp-qty is. 1st period: 507


Azathioprine Oral 50mg

Sl no1: 50mg oral form-qty is. 1st period: 80,082


Brodalumab 210mg Inj

Sl no1: 210mg soil inj in Srp-Qty is. 1st period: 127


Sarilumab Inj

Sl no1: 150mg sol inj in Srp-Qty is. 1st period: 63 - sl no2: 150mg ground inj in pen injected. 1st period: 112 - sl no3: 200mg soil inj in Srp-Qty is. 1st period: 60 - sl no4: 200mg ground inj in pen injected. 1st period: 113


Guselkumab 100mg Inj

Sl no1: 100mg ground inj Srp-Qty is. 1st period: 144


Ibuprofen 400 Mg Inj

Sl no1: 400mg / 100ml soil for perf-qty is. 1st period: 3,654


Blue Patent V Sodium 2.5% Inj

Sl no1: 2.5g / 100ml ground injected. 1st period: 16,692


Naloxone 0.4mg / 1ml Injectable

Sl no1: 0.4mg / 1ml soil inj amp-qty is. 1st period: 57,908

Download full details as .pdf
The Buyer:
CHU de Bordeaux
CPV Code(s):
33600000 - Pharmaceutical products